Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58,590Revenue $M21,848Net Margin (%)11.8Z-Score3.6
Enterprise Value $M57,053EPS $1.6Operating Margin %12.0F-Score5
P/E(ttm))23.4Cash Flow Per Share $6.7Pre-tax Margin (%)11.5Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %-1.2Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %-22.9Current Ratio1.8Lower Leverage y-yY
Price/Cash Flow9.8y-y EBITDA Growth Rate %32.7ROA % (ttm)6.0Higher Current Ratio y-yN
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)10.2Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M1,554ROI % (ttm)9.7Gross Margin Increase y-yN

Gurus Latest Trades with ABT

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 37.973%New holding, 3250000 sh.3,250,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 37.973%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 37.973%Sold Out0
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 37.978%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 37.978%New holding, 118700 sh.118,700
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 37.978%Reduce -4.79%13,727,856
ABTJohn Hussman 2013-06-30 Sold Out -0.52%$34.88 - $38.56
($36.68)
$ 37.974%Sold Out0
ABTVanguard Health Care Fund 2013-06-30 Reduce-0.24%$34.88 - $38.56
($36.68)
$ 37.974%Reduce -18.79%7,591,400
ABTGeorge Soros 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 37.9712%Add 93.84%1,140,752
ABTPRIMECAP Management 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 37.9712%Add 58.55%11,683,747
ABTMario Gabelli 2013-03-31 Add0.01%$31.34 - $35.32
($33.84)
$ 37.9712%Add 40.97%84,215
ABTDaniel Loeb 2013-03-31 Sold Out -1.1%$31.34 - $35.32
($33.84)
$ 37.9712%Sold Out0
ABTJoel Greenblatt 2013-03-31 Sold Out -0.06%$31.34 - $35.32
($33.84)
$ 37.9712%Sold Out0
ABTMeridian Funds 2013-03-31 Sold Out -0.02%$31.34 - $35.32
($33.84)
$ 37.9712%Sold Out0
ABTMason Hawkins 2012-12-31 Add1.43%$30.09 - $34.51
($31.58)
$ 37.9720%Add 85.61%14,754,193
ABTDaniel Loeb 2012-12-31 Buy 1.1%$30.09 - $34.51
($31.58)
$ 37.9720%New holding, 1834000 sh.1,834,000
ABTGeorge Soros 2012-12-31 Add0.3%$30.09 - $34.51
($31.58)
$ 37.9720%Add 194.25%588,500
ABTPRIMECAP Management 2012-12-31 Add0.27%$30.09 - $34.51
($31.58)
$ 37.9720%Add 61.62%7,369,047
ABTRonald Muhlenkamp 2012-12-31 Sold Out -4.7%$30.09 - $34.51
($31.58)
$ 37.9720%Sold Out0
ABTScott Black 2012-12-31 Sold Out -0.33%$30.09 - $34.51
($31.58)
$ 37.9720%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Daniel Loeb 2013-12-313,250,0000.212.1New Buy
ABT Mario Gabelli 2013-12-31197,1830.010.04+110.21%
ABT Vanguard Health Care Fund 2013-12-317,591,4000.490.9
ABT Dodge & Cox 2013-12-3136,93000
ABT PRIMECAP Management 2013-12-3116,135,9081.040.74-0.33%
ABT Mason Hawkins 2013-12-3113,445,3440.872.5-2.06%
ABT George Soros 2013-12-31970,1810.060.32-7.97%
ABT Ray Dalio 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.95-3.11view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.95-3.11view
Blaser Brian JExecutive Vice President 2014-03-03Sell1,441$39.01-3.26view
ASHLEY RICHARD WExecutive Vice President 2014-03-03Sell2,098$39-3.23view
ALLEN HUBERT LExecutive Vice President 2014-03-03Sell1,543$39.03-3.31view
Funck Robert EVice President, Controller 2014-03-03Sell1,413$38.97-3.16view
FREYMAN THOMAS CExecutive Vice President 2014-03-03Sell2,984$39.1-3.48view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.37-4.14view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.01-3.26view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.01-3.26view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Different Opinions on Bio-Rad Laboratories Apr 03 2014 
    Absolute and Relative Valuation Models Indicate the Same: Abbot Is a Buy Mar 31 2014 
    We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
    Lountzis Asset Management Comments on Abbott Laboratories Mar 21 2014 
    Abbott Capturing Incremental Market Share Mar 18 2014 
    Abbvie's Humira Continues to be a Powerful Catalyst for Growth Mar 18 2014 
    Diamond Hill Capital Comments on Abbott Laboratories Jan 15 2014 
    Diamond Hill Capital Large Cap Fund Q3 Commentary Jan 15 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis Nov 21 2013 
    Investing in Generation Y and the Next Great Baby Boom Nov 16 2013 

    More From Our Partners
    A Make or Break Week for Q1 Earnings Season - Earnings Preview Apr 11 2014 - ZACKS

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide